Skip to content
CareAtlas

US patient receives coordinated care for breast cancer lung metastases in Yantai

Fernanda's treatment combined radiotherapy and supportive Chinese medicine, followed by a plan to continue care after returning home.

烟台市中医医院Original publication: Read original

Published by CareAtlas · Editorial policy

Fernanda, a 34-year-old patient from the United States, travelled to Yantai Hospital of Traditional Chinese Medicine after breast cancer spread to her lungs despite surgery in her home country. She sought care from the hospital's First Oncology Department. In an account published in October 2026, the hospital described her assessment, treatment and preparations for continuing care overseas.

A plan developed across specialties

After admission, the team carried out systematic examinations to assess the breast and lung lesions, disease progression and her overall physical condition. Clinicians reviewed how much treatment she could tolerate before defining the next steps.

A multidisciplinary consultation brought together oncology, radiotherapy, thyroid and breast surgery, and medical imaging specialists. They developed an individualized plan combining standard oncological treatment with Chinese medicine support throughout the course, rather than treating her metastatic disease as an isolated symptom.

Radiotherapy and symptom support

The hospital reported completing a planned course of radiotherapy during her stay. Supporting care included Chinese patent medicines administered intravenously, acupoint applications, herbal washes and acupuncture or related physical treatments. Dietary preparations and herbal drinks were also used as part of her individualized care.

The stated care goals included managing discomfort associated with cancer treatment and supporting appetite, sleep and physical strength. These measures accompanied the radiotherapy. They were components of a combined treatment course, so the account does not establish a separate antitumour effect for any one supportive intervention.

Preparing to continue treatment abroad

At the reported assessment, target lesions in the lungs and breast were smaller than at admission. The hospital also reported improved physical condition and no serious treatment-related adverse effects during this stage.

Fernanda could not remain in hospital to complete the entire treatment plan because of personal circumstances. Before she left, the specialists provided a follow-up examination plan and recommendations for continuing chemotherapy. This gave her a basis for arranging ongoing treatment after returning home. The department later received her letter thanking the team for its clinical care and support.

Latest news